SELLAS Life Sciences Group, Inc. (SLS) Net income 2016–2025
SELLAS Life Sciences Group, Inc. (SLS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$26.9MFY2025 · since FY2016: -$17.7M → -$26.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.9M | +13.0% |
| FY2024 | -$30.9M | +17.3% |
| FY2023 | -$37.3M | +9.6% |
| FY2022 | -$41.3M | -99.5% |
| FY2021 | -$20.7M | -23.5% |
| FY2020 | -$16.8M | +13.1% |
| FY2019 | -$19.3M | +30.3% |
| FY2018 | -$27.7M | -16.5% |
| FY2017 | -$23.8M | -34.3% |
| FY2016 | -$17.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice